Drug Injury Lawyers

Actos® Bladder Cancer Settlement Moving Forward

by Staff | October 7th, 2015

Actos® is a drug by Takeda Pharmaceuticals, Inc. used to effectively treat diabetes. Unfortunately, researchers have linked the use of Actos with the development of bladder cancer.

In April, Takeda offered $2.3 billion to settle many of the Actos bladder cancer lawsuits in the wake findings showing a link between the drug and the disease. Now, the settlement is moving forward.

FiercePharma explains that as many as 96 percent of plaintiffs who filed Actos bladder cancer lawsuits agreed to the terms of the settlement after Takeda added another $100,000 to the fund used to compensate the victims.

If the settlement becomes finalized, it will lay to rest seven of the nine Actos bladder cancer lawsuits Takeda is currently facing. A statement from executives at Takeda stated the company hopes the settlement will allow all parties involved to avoid “the uncertainties of complex litigation.”

Despite the settlement, Actos remains on the market and Takeda says they will continue to back the drug in the future.

At Fleschner, Stark, Tanoos & Newlin, we believe in holding drugmakers accountable for the safety of the products they release onto the American market. That’s why our drug injury lawyers are hopeful this settlement can help those who developed bladder cancer as a result of taking Actos get back on their feet.

FDA Calls for Increased Warnings on Zoloft® Due to Drug Injury Risk

by Staff | September 28th, 2015

Zoloft® is a powerful antidepressant drug used to treat a number of mental health conditions. Women who are taking or are considering using this drug should be aware of certain congenital risks the medication may pose to their unborn children if they are, or are considering becoming, pregnant.

Research has shown an increased risk of congenital heart defects in the children who were born to women who took Zoloft during pregnancy. The U.S. Food and Drug Administration (FDA) reports the risks of this particular antidepressant birth defect were as much as six times higher in women who took the drug into the twentieth week of pregnancy as compared to women who birthed children and did not take the drug.

These findings and other research that came to similar conclusions have prompted the FDA to ask the manufacturer of Zoloft, Pfizer, Inc., to change the warning labels on the drug to include information about the increased risk of heart defects, such as persistent pulmonary hypertension, in children born to women who took Zoloft. According to Bloomberg Business, Pfizer maintains the drug is safe for women to use.

If you’re a woman who has been given a prescription for Zoloft, it’s important to be aware of your rights as a patient. If your child was harmed as the result of using the medication, you should also consider taking a look at our website to learn more about the options and resources that are available to those who have suffered a drug injury.

Could Search Engine Results Help Reduce Drug Injury Numbers?

by Staff | July 23rd, 2015

Here in the United States, there are medications capable of treating almost any illness or disease from which we suffer. Unfortunately, many of these medications can cause a patient to experience harmful side effects.

Some side effects can be as relatively benign as drowsiness, while others can cause organs of the body to shut down in some patients. Typically medications are tested to determine possible side effects before the drug is released onto the market, so consumers can be fully informed and warned about the potential dangers of taking a medication. Our drug injury lawyers at Fleschner, Stark, Tanoos & Newlin explain that sometimes though, side effects aren’t discovered until after the medication is made available to the public.

It seems as though technology may prove to be an effective tool in helping to identify the risks of a drug injury. An article from Bloomberg Business explains that the millions of internet searches that are conducted on medication side effects each year could provide insight into undiscovered risks associated with a certain product.

In 2010, a scientist examined 176 million Yahoo! searches and determined those results could be used to identify previously unknown side effects that were associated with certain drugs. More recently, the FDA has been partnering with Google and other organizations to conduct similar research, which has yielded findings that support initial conclusions.

At Fleschner, Stark, Tanoos & Newlin, we support the application of technology to help reduce drug injuries and our Indiana personal injury attorneys are hopeful search engine results can prove useful in identifying harmful side effects and potentially preventing drug injuries in the future.

Drug Injury Lawyers Examine The Possibility of Consolidating Zofran® Drug Injury Lawsuits

by Staff | July 16th, 2015

Many women experience bouts of nausea during pregnancy. There are medications that are available to help treat morning sickness, but our drug injury lawyers at Fleschner, Stark, Tanoos & Newlin explain some of these pharmaceuticals may put the patient’s child at serious risk of birth defects.

Several studies have linked taking the anti-nausea drug, Zofran® while pregnant to children born with serious birth defects. Researchers from three separate teams concluded children who were exposed to Zofran while still in the womb faced an increased risk of congenital heart defects. Still another study found children of mothers who used Zofran while pregnant face two times the risk of being born with a cleft palate.

These conditions, and a lack of information regarding the risks of taking this particular medication, have led to many Zofran drug injury lawsuits being filed by victims. In fact, so many claims have been filed, Reuters reports the manufacturer of the drug, GlaxoSmithKline, has asked the courts to consolidate the cases into one courtroom through multidistrict litigation (MDL).

This move means that more lawsuits are expected to be filed soon. So, if you or your child were harmed as the result of exposure to the drug Zofran, you may wish to speak with a qualified attorney regarding your legal rights to compensation.

At Fleschner, Stark, Tanoos & Newlin, our team of personal injury attorneys are standing by to provide you with answers to any questions you may have. Feel free to contact us anytime by calling (800) 477-7315.

What You Need To Know About Xarelto® Bleeding Injuries

by Staff | June 10th, 2015

Certain diseases and medical conditions can increase your chance of developing deadly blood clots in your arteries. Luckily, medications are available to prevent these clots from forming, but some of the drugs that are available increase the risks of other serious adverse health effects.

Xarelto® is one of those medications. The drug can effectively prevent blood clots while not requiring as much monitoring by medical professionals as other treatment options; however, our Xarelto® drug injury lawyers at Fleschner, Stark, Tanoos & Newlin point out that numerous studies have shown the drug can increase the chances of patients suffering uncontrollable bleeding events. Furthermore, there is no antidote to the drug to stop the bleeding, whereas most other medications can be controlled by administering a counteracting drug.

Some victims of Xarelto® bleeding injuries have accused the drug’s manufacturer of hiding these risks and have filed lawsuits in order to receive compensation for the harm that was done. The makers of Xarelto® have denied the allegations and, according to an article from RTT News, are conducting new research to determine the risks of taking the medication.

While this research could potentially be a step in the right direction toward ensuring the safety of those who take Xarelto®, it could take years to complete. In the meantime, patients who are continuing to take the drug may be harmed and these individuals have rights that need to be protected.

Our team of drug injury lawyers at Fleschner, Stark, Tanoos & Newlin understand the intricacies of how the law regulates drug safety in the United States. We’re here to answer your questions if you’ve been harmed as the result of using Xarelto®.

Risk of Low Testosterone Drug Heart Attacks Prompts FDA to Require Warning Label Changes

by Staff | May 6th, 2015

Doctors have been prescribing medications containing testosterone to men for years to treat symptoms of aging such as low energy levels, decreased body mass, and decreased sex drive. However, these medications can put some users at risk of suffering adverse cardiac events. The dangers of low testosterone drug heart attacks and strokes has prompted the U.S. Food and Drug Administration (FDA) to mandate changes to the warning labels of these products.

A press release from the agency explains low testosterone or “low T” drugs are only approved to treat men suffering from clinically defined low testosterone levels, stemming from conditions of the testicles, pituitary gland, or brain. The FDA goes on to say studies have shown men with a history of heart disease who use these medications may be at an even greater risk of heart attack or stroke.

In response, the FDA has requested that manufacturers of low testosterone drugs change the labels of these products to reflect the dangers low T drugs pose. The agency is also asking manufacturers to conduct clinical trials on their products to more clearly identify potential risks.

Officials add that patients using low testosterone medications should halt use immediately if they experience chest pain, slurred speech, shortness of breath, or weakness in one side of the body.

At Fleschner, Stark, Tanoos & Newlin, we’ve seen the damage off-label marketing of drugs can cause and our drug injury lawyers are hopeful these new requirements will help reduce the number of injuries associated with low testosterone therapy medications.

Study Pinpoints Increase in Lipitor® Diabetes Risk

by Staff | March 25th, 2015

High cholesterol is one of the most commonly diagnosed medical conditions in the United States, considering there are currently more than 71 million confirmed cases in our country today. There are medications on the market that can be used to treat high cholesterol, but one of the most popular could be putting the health of users at serious risk.

The drug Lipitor® is in a class of drugs called statins that can be used to lower cholesterol levels. The medication generated $2.1 billion in revenue in the United States last year, making it one of the most commonly prescribed medications to treat high cholesterol. What many users didn’t realize though, is that the drug can significantly raise a patient’s chances of developing Type II Diabetes.

Studies have shown taking statins like Lipitor® can increase a user’s glucose levels, driving up the potential for developing diabetes further down the road. A report from Bloomberg Business identified data that shows taking Lipitor® can raise an individual’s risk of developing diabetes by as much as 46 percent.

Despite a known Lipitor® diabetes risk, the drug remains readily available on the market today and continues to put patients’ health in danger.

If you or a loved one have developed diabetes after taking Lipitor®, it’s important to know that you may be entitled to compensation. Speaking with an attorney is the best way to make the determination as to whether or not you qualify and the drug injury attorneys at the law firm of Fleschner, Stark, Tanoos & Newlin are standing by to assist you. Feel free to reach out to us anytime for a free consultation of your case by calling (800) 477-7315.

FDA Lays Out New Guidelines for Information on Drug Labels

by Staff | December 10th, 2014

A medication may be deemed safe for human consumption,  but if you’re a woman who is or may become pregnant, that drug may pose a serious health threat to your unborn child.

Researchers have gathered evidence that shows taking certain mood-altering drugs—known as Selective Serotonin Reuptake Inhibitors (SSRIs)— while pregnant can cause a child to be born with an antidepressant birth defect called persistent pulmonary hypertension.

Being aware of how a drug may interact with the child you’re carrying is important, considering estimates show as many as 3 in 5 women will regularly take medication during pregnancy; however, the labeling of medications can make it difficult to decipher which drugs are safe and which are dangerous.

Federal officials are addressing this issue by revamping what information is displayed on a drug’s label. CBS News reports that beginning next summer the labels of medications must carry any and all available information about the effects a drug could have on a woman or child during pregnancy or while nursing. This must include whether testing was conducted on human or animal subjects.

In the meantime, the drug injury lawyers at Fleschner, Stark, Tanoos & Newlin encourage women to discuss any questions they may have about a medication that’s been prescribed to them with their doctor or pharmacist. If you or your child have suffered a drug injury that was caused by a medication you were given, you may want to speak with an attorney about your potential legal rights to compensation. Our team is available to discuss your case anytime by calling (800) 477-7315.